Nivolumab
MCC-19122
Phase 1 small_molecule completed
Quick answer
Nivolumab for Non-Small Cell Lung Cancer is a Phase 1 program (small_molecule) at Iovance Biotherapeutics B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Iovance Biotherapeutics B.V.
- Indication
- Non-Small Cell Lung Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed